About Us
We are on a mission to re-write the rules of drug discovery.
“At Cellarity, we take a holistic view of diseases and biology from the very beginning. I believe that that will lead to much better treatments down the road.”
Max Rogers-Grazado, Scientist
Meet The Team
Our Leadership Team
We are a team of experts who see the world from a new perspective. By combining our expertise in drug development, genomic technologies, systems biology, data science and AI, we are striving to develop a new generation of “game-changing” medicines for patients.
Our Founders
We are founded by a visionary team on a mission to push the boundaries of drug discovery in service of patients. Hailing from both Flagship Pioneering and academia, our roots lie in asking “What if…?” and finding the answers.
Our Board
Our Board includes industry leading experts from the pharma, biotech and tech industries. Energized by our mission to create medicines currently out of reach to patients in need, our Board embraces our passion for harnessing the power of AI and single-cell omics data to see disease biology others can’t.
Anjali Kumar
Anna O’Driscoll
Atli Thorarensen
Cameron Trenor
Chad Nusbaum
Fabrice Chouraqui
Govinda Bhisetti
Kat Guillen
John Leaman
Kelly Dennehy
Kevin Henry
Laurens Kruidenier
Matt Goddeeris
Parul Doshi
Rajiv Amin
Scott Steelman
Stephen Berenson
Avak Kahvejian
Jim Collins
Marcello Damiani
Ian Estepan
Sandra Horning
Gregory Moore
Nick Plugis
Noubar Afeyan
Cellarity was created by Flagship Pioneering and launched in December 2019. We recognized that powerful new biological and computational technologies exist to perturb and quantify diverse cellular or molecular disease signatures. Harnessing these technologies allows us to move away from reductionist drug discovery, and unravel the complexities of disease biology to produce “game-changing” medicines out of reach previously.
Discover More
Platform
Pipeline
Life at Cellarity
